Nano-golden adjuvant-polymersomes empower tumor photothermal-immunotherapy

IF 10.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Zhiwei Sun, Jingyi Wang, Beibei Guo, Songsong Zhao, Shiyu Miao, Mingyu Xia, Zhiyuan Zhong, Fenghua Meng
{"title":"Nano-golden adjuvant-polymersomes empower tumor photothermal-immunotherapy","authors":"Zhiwei Sun, Jingyi Wang, Beibei Guo, Songsong Zhao, Shiyu Miao, Mingyu Xia, Zhiyuan Zhong, Fenghua Meng","doi":"10.1016/j.jconrel.2025.113976","DOIUrl":null,"url":null,"abstract":"The integration of photothermal therapy with immunotherapy represent a potential treatment for tumor patients. Here, we demonstrate that nano‑golden adjuvant-polymersomes (nGAP) with gold nanoclusters imbedded in the membrane and immunoadjuvant poly(I:C) encapsulated within the aqueous core empower tumor photothermal-immunotherapy. Upon near-infrared irradiation, nGAP elicits a strong photothermal effect on tumor cells, driving immunogenic cell death and activating dendritic cells. In murine LLC lung tumor models, a single session of irradiation following intratumoral injection of nGAP led to an impressive 83 % cure rate, which further increased to 100 % complete regression by equipping cRGD peptide on the polymersome surface and combining with anti-CTLA-4 antibody. Furthermore, the cured mice exhibited effective resistance to subsequent tumor re-challenges. Our findings also reveal that nGAP yields explicit abscopal effects, supporting the development of systemic and long-lasting anticancer immunity. nGAP presents an interesting therapeutic modality capable of effectively ablating both primary solid tumors and their metastatic counterparts.","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"7 1","pages":""},"PeriodicalIF":10.5000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jconrel.2025.113976","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

The integration of photothermal therapy with immunotherapy represent a potential treatment for tumor patients. Here, we demonstrate that nano‑golden adjuvant-polymersomes (nGAP) with gold nanoclusters imbedded in the membrane and immunoadjuvant poly(I:C) encapsulated within the aqueous core empower tumor photothermal-immunotherapy. Upon near-infrared irradiation, nGAP elicits a strong photothermal effect on tumor cells, driving immunogenic cell death and activating dendritic cells. In murine LLC lung tumor models, a single session of irradiation following intratumoral injection of nGAP led to an impressive 83 % cure rate, which further increased to 100 % complete regression by equipping cRGD peptide on the polymersome surface and combining with anti-CTLA-4 antibody. Furthermore, the cured mice exhibited effective resistance to subsequent tumor re-challenges. Our findings also reveal that nGAP yields explicit abscopal effects, supporting the development of systemic and long-lasting anticancer immunity. nGAP presents an interesting therapeutic modality capable of effectively ablating both primary solid tumors and their metastatic counterparts.

Abstract Image

纳米金佐剂-聚合体增强肿瘤光热免疫治疗
光热疗法与免疫疗法的结合为肿瘤患者提供了一种潜在的治疗方法。在这里,我们证明了纳米金佐剂聚合体(nGAP)嵌入在膜上,免疫佐剂聚(I:C)包裹在水核内,增强了肿瘤光热免疫治疗。在近红外照射下,nGAP对肿瘤细胞产生强烈的光热效应,驱动免疫原性细胞死亡并激活树突状细胞。在小鼠LLC肺肿瘤模型中,在瘤内注射nGAP后进行单次照射,治愈率达到令人震惊的83% %,通过在聚合体表面配备cRGD肽并结合抗ctla -4抗体,治愈率进一步提高到100% %。此外,治愈的小鼠对随后的肿瘤再攻击表现出有效的抵抗力。我们的研究结果还表明,nGAP产生明确的体外效应,支持系统和持久的抗癌免疫的发展。nGAP提出了一种有趣的治疗方式,能够有效地消融原发性实体瘤和转移性肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信